Table of Contents
Chapter one: Executive Summary
- Introduction
- Blood Transfusion Demand and Supply
- Synthetic Blood Products
- Summary Market Forecast
- Scope and Methodology
Chapter Two: Introduction: Blood, Associated Disorders, and Blood Products
- Composition, Function and Formation
- o Red Blood Cells (Erythrocytes)
- o White Blood Cells (Leukocytes)
- o Platelets
- o Plasma
- Blood Transfusions
- Synthetic Blood Products: A Suitable Alternative
- o Blood Volume Expanders
- o Hemoglobin Based Oxygen Carriers
- o Perflurocarbon (PFC) Based Blood Products
- o Factor Products for Hemophilia A
- o Synthetic Platelets
- o Synthetic Blood Products Summary
Chapter Three: Novel Synthetic Blood Products in Clinical Trials
- Hemolink (Hemosol)
- Hemopure (Biopure)
- Polyheme (Northfield Laboratories)
- Oxygent (Alliance)
- Oxycyte (Synthetic Blood International)
- PHER-O2 (Sanguine)
- Albrec (Mitsubishi Pharma)
- Advate (Baxter)
- Recombinant Factors
- Synthocytes (Andaris)
- Gene Therapy
Chapter Four: Worldwide Demand and Market Analysis
- Blood Shortage Driving Demand for Alternatives
- Blood Volume Expanders
- Oxygen Carrier Market
- Recombinant Factor Market
Chapter Five: Key Players and Their Technologies
- Alliance Pharmaceuticals Inc.
- Biopure Corp.
- BioTime Inc.
- Hemosol Corp.
- JP Laboratories Inc.
- Northfield Laboratories
- Novo Nordisk A/S
- Perftoran
- Sanguine Corp.
- Synthetic Blood International
- Transkaryotic Therapies Inc.
List of Exhibits
- Exhibit 1: Worldwide Demand for Red Blood Cells by Indication (Acute vs Chronic)
- Exhibit 2: Summary of World Demand for RBCs 2003-2009
- Exhibit 3: Number of High Blood Loss Surgical Procedures by Type
- Exhibit 4: High Blood Loss Market: HBOC and PFC Agents 2007-2013
- Exhibit 5: World Recombinant Factor Market Summary 2003-2009
- Exhibit 6: World Market for Gene Therapy in Blood Disorders 2006-2011
- Exhibit 7: Composition of Blood Plasma
- Exhibit 8: Clinical Uses for Blood Substitutes
- Exhibit 9: HBOCs Sources and Modification by Company
- Exhibit 10: Recombinant Factor Products in Clinical Trials
- Exhibit 11: Average Blood and Component Requirements by Condition
- Exhibit 12: Annual Worldwide Demand for Red Blood Cells
- Exhibit 13: Geographical Distribution of RBC Demand by Region (United States, Europe, Japan, ROW) 2003
- Exhibit 14: Projected World Demand for RBCs 2003-2009
- Exhibit 15: Number of High Blood Loss Surgical Procedures by Type (Number of Procedures, Units of RBCs per Procedure, Total Units Transfused, Market Value) 2003
- Exhibit 16: Blood Volume Expanders Market by Brand 2002-2009
- Exhibit 17: High Blood Loss Market HBOC and PFC Agent Revenues 2007-2013
- Exhibit 18: World Recombinant Factor Market by Brand 2003-2009
| 
View Cart
